Bioasis Technologies (OTCMKTS:BIOAF) Shares Pass Above 50 Day Moving Average – Time to Sell?

Bioasis Technologies Inc. (OTCMKTS:BIOAF) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Bioasis Technologies shares last traded at $0.00, with a volume of 0 shares trading hands.

Bioasis Technologies Stock Down 100.0%

About Bioasis Technologies

Bioasis Technologies Inc is a clinical-stage biotechnology company based in Vancouver, Canada, focused on advancing novel delivery technologies to transport therapeutic molecules across the blood–brain barrier (BBB). The company’s proprietary Blood–Brain Barrier Transport (BBBT) platform is designed to enable targeted delivery of peptides, proteins and enzyme replacement therapies to the central nervous system, addressing a critical challenge in treating neurological and rare lysosomal storage disorders.

Bioasis’s pipeline leverages its BBBT platform to develop preclinical candidates for a range of central nervous system indications.